These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6315427

  • 1. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
    Wise R, Andrews JM.
    Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427
    [Abstract] [Full Text] [Related]

  • 2. The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid.
    Kalager T, Digranes A, Bergan T, Solberg CO.
    J Antimicrob Chemother; 1984 May; 13(5):479-85. PubMed ID: 6330020
    [Abstract] [Full Text] [Related]

  • 3. Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.
    Wise R, Baker S, Livingston R.
    Antimicrob Agents Chemother; 1980 Sep; 18(3):369-71. PubMed ID: 6252833
    [Abstract] [Full Text] [Related]

  • 4. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M, Grégoire S, Caron M, Bergeron MG.
    Antimicrob Agents Chemother; 1985 Jul; 28(1):123-7. PubMed ID: 4037771
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C.
    Chemotherapy; 1985 Jul; 31(2):85-94. PubMed ID: 3987394
    [Abstract] [Full Text] [Related]

  • 6. A study of the relationship between dose and pharmacokinetics of ceftriaxone.
    Findlay CD, Brown RM, Allcock JE, Lowe PA, Wise R.
    J Antimicrob Chemother; 1982 Jan; 9(1):57-62. PubMed ID: 6277840
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.
    Meyers BR, Srulevitch ES, Jacobson J, Hirschman SZ.
    Antimicrob Agents Chemother; 1983 Nov; 24(5):812-4. PubMed ID: 6318657
    [Abstract] [Full Text] [Related]

  • 9. Activity of third-generation cephalosporins in human blood.
    Shah PM, Jaenisch E.
    Clin Ther; 1983 Nov; 6(1):72-8. PubMed ID: 6325006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Entry of four cephalosporins into the ovine lung.
    Cohen SH, Hoeprich PD, Demling R, Gunther R, Merry JM, Franti CE, Miner DJ.
    J Infect Dis; 1984 Feb; 149(2):264-70. PubMed ID: 6321609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
    Lüthy R, Blaser J, Bonetti A, Simmen H, Wise R, Siegenthaler W.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):567-75. PubMed ID: 6275776
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
    Noble JT, Barza M.
    Drugs; 1985 Sep; 30(3):175-81. PubMed ID: 3899596
    [No Abstract] [Full Text] [Related]

  • 16. Investigation of human bile and serum levels by high pressure liquid chromatography after administration of latamoxef or cefotaxime.
    Krausse R, Ullmann U, Brandstetter G, Kratochvil P.
    Arzneimittelforschung; 1984 Sep; 34(12):1787-91. PubMed ID: 6099130
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF.
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [Abstract] [Full Text] [Related]

  • 19. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V, Bismuth R, Grosset J.
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction.
    Wise R, Wright N.
    Infection; 1985 May; 13 Suppl 1():S145-50. PubMed ID: 4055047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.